Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$12.46
+0.2%
$11.25
$4.88
$13.14
$1.82B1.062.04 million shs1.42 million shs
DNAA
Social Capital Suvretta Holdings Corp. I
$14.07
$11.74
$9.07
$17.44
$360.76M-0.02182,488 shs4.63 million shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$12.68
-0.2%
$16.23
$11.60
$32.66
$985.39M1.271.04 million shs980,705 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$21.28
+0.6%
$19.44
$15.75
$53.69
$1.42B1.471.49 million shs1.68 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
+0.16%-0.16%+11.15%-0.56%+21.80%
DNAA
Social Capital Suvretta Holdings Corp. I
0.00%0.00%0.00%0.00%0.00%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
-0.16%+0.16%-26.92%-45.37%-57.16%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+0.61%+3.10%+26.89%-3.88%-58.88%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
4.13 of 5 stars
3.41.00.03.33.14.20.6
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.5733 of 5 stars
3.91.00.04.03.11.72.5
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.3052 of 5 stars
4.31.00.04.92.91.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.89
Moderate Buy$17.8943.57% Upside
DNAA
Social Capital Suvretta Holdings Corp. I
0.00
N/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
1.78
Reduce$18.6346.88% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.50
Moderate Buy$37.4776.07% Upside

Current Analyst Ratings Breakdown

Latest DNAA, ATEC, IART, and TNDM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$20.00 ➝ $24.00
5/9/2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$35.00 ➝ $25.00
5/6/2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $13.00
5/6/2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$24.00 ➝ $12.00
5/2/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$13.00 ➝ $15.00
5/2/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$58.00 ➝ $59.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $31.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $20.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$36.00 ➝ $30.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$33.00 ➝ $24.00
(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$642.27M2.84N/AN/A$0.57 per share21.86
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/A($0.33) per shareN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.62B0.61$2.78 per share4.56$20.31 per share0.62
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$982.95M1.44N/AN/A$4.81 per share4.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$186.64M-$1.15N/AN/AN/A-31.06%-541.39%-22.99%7/30/2025 (Estimated)
DNAA
Social Capital Suvretta Holdings Corp. I
-$2.44MN/A0.00N/AN/AN/A-3.32%N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M-$0.38N/A5.070.73-0.42%12.35%4.82%8/4/2025 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$2.78N/AN/AN/A-14.84%-44.19%-11.99%8/7/2025 (Estimated)

Latest DNAA, ATEC, IART, and TNDM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2025Q1 2025
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.43$0.41-$0.02-$0.33$381.17 million$382.65 million
5/1/2025Q1 2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.12-$0.35-$0.23-$0.35$167.57 million$169.18 million
4/30/2025Q1 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.60-$0.67-$0.07-$1.97$220.19 million$234.42 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
30.21
2.32
1.15
DNAA
Social Capital Suvretta Holdings Corp. I
N/A
0.09
0.09
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.79
1.20
0.73
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.29
2.90
2.32
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
700146.17 million109.48 millionOptionable
DNAA
Social Capital Suvretta Holdings Corp. I
425.64 millionN/ANot Optionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,72077.71 million74.77 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,60066.61 million64.23 millionOptionable

Recent News About These Companies

Tandem agrees to pay $36M to settle Roche patent litigation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alphatec stock logo

Alphatec NASDAQ:ATEC

$12.46 +0.02 (+0.16%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$12.85 +0.39 (+3.13%)
As of 05/29/2025 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Social Capital Suvretta Holdings Corp. I NASDAQ:DNAA

Social Capital Suvretta Holdings Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$12.68 -0.02 (-0.16%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$12.60 -0.08 (-0.67%)
As of 05/29/2025 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$21.28 +0.13 (+0.61%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$21.30 +0.02 (+0.09%)
As of 05/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.